News Release

May 30, 2014 at 4:05 PM EDT

Regeneron Announces Update to Upcoming 2014 Investor Conference Presentations

TARRYTOWN, N.Y., May 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its management presentation at the following investor conferences:

  • Jefferies 2014 Global Healthcare Conference at 8:30 AM Eastern Time on Thursday, June 5, 2014
  • 2014 Annual Meeting of Shareholders of Regeneron Pharmaceuticals, Inc., at 10:30 AM Eastern Time on Friday June 13, 2014

The session may be accessed through the Company's web site,, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

Regeneron will no longer be participating in the following previously scheduled investor conference:

  • Goldman Sachs 35th Annual Global Healthcare Conference previously scheduled for 2:20 PM Eastern Time (11:20 AM Pacific Time) on Tuesday, June 10, 2014

About Regeneron Pharmaceuticals

Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis.  For additional information about the company, please visit

Contact Information:                                         

Manisha Narasimhan, Ph.D.   

Hala Mirza

Investor Relations    

Corporate Communications                           



SOURCE Regeneron Pharmaceuticals, Inc.

News Provided by Acquire Media